Targeting of Vascular Adhesion Protein-1 by Positron Emission Tomography Visualizes Sites of Inflammation in Borrelia Burgdorferi-infected Mice
Overview
Authors
Affiliations
Background: In the present study, we sought to evaluate the feasibility of targeting vascular adhesion protein-1 (VAP-1) by positron emission tomography (PET) for the longitudinal quantitative assessment of Borrelia burgdorferi infection-induced inflammation in mice.
Methods: Mice with B. burgdorferi infection-induced arthritis were studied. During a 7-week follow-up period, the progression of arthritis was monitored weekly with Ga-DOTA-Siglec-9 PET/computed tomography (CT) and measurement of tibiotarsal joint swellings. A subgroup of infected mice was treated with ceftriaxone. Finally, histopathological assessment of joint inflammation was performed and VAP-1 expression in joints were determined.
Results: Explicit joint swelling and Ga-DOTA-Siglec-9 uptake could be demonstrated in the affected joints from B. burgdorferi-infected mice. By contrast, no obvious accumulation of Ga-DOTA-Siglec-9 was detected in joints of uninfected mice. The maximum swelling and highest uptake in the affected joints were observed 4 weeks after the infection. Ga-DOTA-Siglec-9 uptake in joints correlated with joint swelling (P < 0.0001) and histopathological scoring of inflammation (P = 0.020). Despite short-term antibiotic treatment, the arthritis persisted, and the PET signal remained as high as in nontreated mice. Immunohistochemistry revealed strong-to-moderate expression of VAP-1 in the synovium of B. burgdorferi-infected mice, while only weak expression of VAP-1 was detected in uninfected mice.
Conclusions: The present study showed that Ga-DOTA-Siglec-9 can detect B. burgdorferi infection-induced arthritis in mice. Furthermore, longitudinal PET/CT imaging allowed monitoring of arthritis development over time.
Bhowmik A, Heikkila T, Polari L, Virta J, Liljenback H, Moisio O Mol Imaging Biol. 2023; 26(2):322-333.
PMID: 38110791 PMC: 10973022. DOI: 10.1007/s11307-023-01885-8.
Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis.
Jahandideh A, Virta J, Li X, Liljenback H, Moisio O, Ponkamo J J Nucl Cardiol. 2023; 30(6):2760-2772.
PMID: 37758963 PMC: 10682147. DOI: 10.1007/s12350-023-03371-8.
Verschoor Y, Vrijlandt A, Spijker R, van Hest R, Ter Hofstede H, van Kempen K Clin Microbiol Rev. 2022; 35(4):e0007422.
PMID: 36222707 PMC: 9769629. DOI: 10.1128/cmr.00074-22.
Adventures in radiosynthesis of clinical grade [Ga]Ga-DOTA-Siglec-9.
Kakela M, Luoto P, Viljanen T, Virtanen H, Liljenback H, Jalkanen S RSC Adv. 2022; 8(15):8051-8056.
PMID: 35542034 PMC: 9078465. DOI: 10.1039/c7ra12423f.
First-in-Humans Study of Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1.
Viitanen R, Moisio O, Lankinen P, Li X, Koivumaki M, Suilamo S J Nucl Med. 2020; 62(4):577-583.
PMID: 32817143 PMC: 8049366. DOI: 10.2967/jnumed.120.250696.